Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis

Ver/ abrir
Use este enlace para citar
http://hdl.handle.net/2183/29053
A non ser que se indique outra cousa, a licenza do ítem descríbese como Atribución-NoComercial-SinDerivadas 3.0 España
Coleccións
- Investigación (FCS) [1293]
Metadatos
Mostrar o rexistro completo do ítemTítulo
Mitochondrial biogenesis: a potential therapeutic target for osteoarthritisData
2020-05-14Cita bibliográfica
Blanco FJ, Fernández-Moreno M. Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis.Osteoarthritis Cartilage. 2020;28(8):1003-6
Resumo
[Abstract] Mitochondrial dysfunction of human articular chondrocytes is considered a hallmark of cartilage degradation and OA pathogenesis. Due to the huge number of cellular processes in which mitochondria is implicated, even in the closed context of cellular respiration, the term mitochondrial function can refer to a variety of features which include fusion and fission, turnover (biogenesis and mitophagy), and plasticity. Mitochondrial biogenesis and mainly mitochondrial fusion and reduced mitophagy, contribute to the metabolic disorder and inflammation that occurs during OA. Reduced MFN2 and increased PARKIN expression represent potential therapeutic targets for the treatment of joint cartilage degradation during the OA process.
Palabras chave
Mfn2
Mitochondrial dynamics
Osteoarthritis
Mitochondrial dynamics
Osteoarthritis
Descrición
Editorial
Versión do editor
Dereitos
Atribución-NoComercial-SinDerivadas 3.0 España
ISSN
1063-4584